Study of MG-K10 for moderate to severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 12 and 75 years old and weigh at least 66 pounds (30 kg).
- Have had asthma for at least 1 year and currently use a high-dose inhaled steroid plus another controller medicine (like a long-acting bronchodilator) for at least 2 months.
- Have had at least 1 asthma flare-up in the past year that needed steroids by mouth or IV, or a hospital or emergency room visit.
- Have a lung function test (FEV1) that is 80% or less of normal for adults (or 90% or less for teens), measured before using a rescue inhaler.
- Agree to use effective birth control from the start of the study until 6 months after the last dose.
- Be able to understand the study and sign a consent form (parents also need to sign for teens).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called SHR-1905 for people with severe asthma that is not well controlled by their current treatments. The study aims to see if the drug can reduce asthma attacks and improve breathing.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.